Trends for Clinical Trials on Medicinal Products for Neurological Disorders in Lithuania and Europe
Background. As the global burden of neurological diseases has been increasing, clinical trials have become more important. Yet, no systematic analysis of clinical trials of neurological medicinal products has been done in Europe and, specifically, in Lithuania. The aim of this study is to evaluate...
Saved in:
Main Authors: | Emilijus Žilinskas, Arūnas Vaitkevičius |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2024-03-01
|
Series: | Neurologijos seminarai |
Subjects: | |
Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/34916 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trials
by: Alqassem Y. Hakami, et al.
Published: (2025-02-01) -
Use of Complementary and Alternative Medicine Practices in Patients Admitted to The Pediatric Neurology Outpatient Clinic
by: Deniz Yüksel, et al.
Published: (2023-06-01) -
Psychobiotics, Novel Therapeutic Agents for the Psychiatric Disorders
by: Praveen Reddy P., et al.
Published: (2025-02-01) -
Conducting clinical trials with self-collection of pharmacokinetic samples: Experience from an exploratory, phase 1, open-label trial of centanafadine SR in healthy individuals
by: Chelsea Ye, et al.
Published: (2025-02-01) -
Gaps in the ethical governance of pharmaceutical clinical trials in Europe
by: Rosemarie D. L. C. Bernabe, et al.
Published: (2025-01-01)